<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Womens Health (Larchmt)</journal-id><journal-id journal-id-type="iso-abbrev">J Womens Health (Larchmt)</journal-id><journal-id journal-id-type="pmc-domain-id">1162</journal-id><journal-id journal-id-type="pmc-domain">jwh</journal-id><journal-id journal-id-type="publisher-id">jwh</journal-id><journal-title-group><journal-title>Journal of Women's Health</journal-title></journal-title-group><issn pub-type="ppub">1540-9996</issn><issn pub-type="epub">1931-843X</issn><publisher><publisher-name>Mary Ann Liebert, Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10329150</article-id><article-id pub-id-type="pmcid-ver">PMC10329150.1</article-id><article-id pub-id-type="pmcaid">10329150</article-id><article-id pub-id-type="pmcaiid">10329150</article-id><article-id pub-id-type="pmid">36827080</article-id><article-id pub-id-type="doi">10.1089/jwh.2022.0322</article-id><article-id pub-id-type="publisher-id">10.1089/jwh.2022.0322</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Prepregnancy Cardiovascular Disease Risk Factors and Adverse Pregnancy Outcomes in a Safety-Net Hospital</article-title><alt-title alt-title-type="left-running-head">Murray Horwitz et al.</alt-title><alt-title alt-title-type="right-running-head">CVD Risk Before and During Pregnancy</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Murray Horwitz</surname><given-names initials="ME">Mara E.</given-names></name><degrees>MD, MPH</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="corr1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prifti</surname><given-names initials="CA">Christine A.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Battaglia</surname><given-names initials="TA">Tracy A.</given-names></name><degrees>MD, MPH</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ajayi</surname><given-names initials="AT">Ayodele T.</given-names></name><degrees>MBBS, MPH</degrees><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names initials="CV">Camille V.</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benjamin</surname><given-names initials="EJ">Emelia J.</given-names></name><degrees>MD, ScM</degrees><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yarrington</surname><given-names initials="CD">Christina D.</given-names></name><degrees>MD</degrees><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Parker</surname><given-names initials="SE">Samantha E.</given-names></name><degrees>PhD, MSPH</degrees><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Women's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.</aff><aff id="aff2"><label><sup>2</sup></label>Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.</aff><aff id="aff3"><label><sup>3</sup></label>Section of Hematology/Oncology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.</aff><aff id="aff4"><label><sup>4</sup></label>Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.</aff><aff id="aff5"><label><sup>5</sup></label>Department of Obstetrics and Gynecology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.</aff></contrib-group><author-notes><fn id="fn1" fn-type="other"><p>Preliminary findings were presented at the 43rd annual meeting of the Society of General Internal Medicine, which was held virtually, between April 20 and April 23, 2021.</p></fn><corresp id="corr1">Address correspondence to: Mara E. Murray Horwitz, MD, MPH, Women's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center, Boston University School of Medicine, 801 Massachusetts Avenue, Crosstown Building 2, Boston, MA 02118, USA <email>mara.murrayhorwitz@bmc.org</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2023</year><string-date>April 2023</string-date></pub-date><pub-date pub-type="epub"><day>04</day><month>4</month><year>2023</year></pub-date><volume>32</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">432971</issue-id><fpage>401</fpage><lpage>408</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-01 00:25:15.120"><day>01</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023, Mary Ann Liebert, Inc., publishers</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Mary Ann Liebert, Inc., publishers</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jwh.2022.0322.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="jwh.2022.0322.pdf"/><abstract><sec id="S009"><title>Background:</title><p>Many adverse pregnancy outcomes (APOs) are associated with elevated cardiovascular disease (CVD) risk. However, APO data in the context of pre-existing CVD risk factors, and from diverse populations, are limited. We assessed the occurrence of APOs among individuals with and without prepregnancy CVD risk factors, overall and by race/ethnicity.</p></sec><sec id="S010"><title>Methods:</title><p>We conducted a retrospective study using electronic medical record data from a large urban safety-net hospital. Individuals with prenatal care and delivery between 2016 and 2018 at the hospital were included, and data from prenatal intake through the delivery hospitalization were captured. The exposure, prepregnancy CVD risk factors (hypertension, diabetes, tobacco use, and obesity), and the outcome, APOs (hypertensive disorders of pregnancy, gestational diabetes, preterm delivery, low birth weight, and stillbirth), were identified from electronic medical records.</p></sec><sec id="S011"><title>Results:</title><p>We identified 3760 unique delivering individuals, of whom 55.1% self-identified as Black non-Hispanic and 17% as Hispanic. Prepregnancy CVD risk factor prevalence was 45.6%, most commonly obesity (26.6%). APO prevalence was 35.6%, most commonly a hypertensive disorder of pregnancy (20.1%). Overall, 45.7% of APOs occurred in the absence of recognized prepregnancy CVD risk factors, representing 16.3% of the total sample. Among individuals without prepregnancy CVD risk factors, APO prevalence was 30.0% and did not vary by race/ethnicity.</p></sec><sec id="S012"><title>Conclusions:</title><p>In this racially and ethnically diverse hospital-based sample, APOs were present in one in three parous individuals without prepregnancy CVD risk factors&#8212;a group with potentially elevated CVD risk who might otherwise be missed by traditional CVD risk factor screening.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>preconception</kwd><kwd>hypertension</kwd><kwd>diabetes</kwd><kwd>cardiovascular disease risk</kwd><kwd>adverse pregnancy outcomes</kwd></kwd-group><counts><fig-count count="3"/><table-count count="3"/><ref-count count="24"/><page-count count="8"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>